🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study is being conducted to evaluate the efficacy and safety of convers...
Status
Completed
Location
Shandong Cancer Hospital and Institute
Start Date
2021-03-17
Trial ID
NCT05099848
Treatments Being Tested
This is an Open Label, Prospective, Multicentre, Non-interventional Study o...
Status
Unknown
Location
Department of Oncology and Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Start Date
2015-09
Trial ID
NCT02668380
The study is to evaluate the efficacy and safety of Apatinib for later trea...
Status
Unknown
Location
Guilin Medical University
Start Date
2017-01-01
Trial ID
NCT03130270
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and toxicity of apatin...
Status
Completed
Location
Sun Yat-sen University Cancer Center
Start Date
2016-08-10
Trial ID
NCT02867956
This study evaluated the tolerance, safety and efficacy of Apatinib plus Do...
Status
Unknown
Location
Sir Run Run Shaw Hospital
Start Date
2015-10
Trial ID
NCT03071042
(1) Evaluate the efficacy of apatinib in combination with standard second-l...
Status
Unknown
Location
Multiple Locations
Start Date
2018-02-28
Trial ID
NCT03412994
Treatments Being Tested
This study is a prospective single-center clinical study, which aims to obs...
Status
Recruiting
Location
Beijing Sanbo Brain Hospital
Start Date
2020-10-28
Trial ID
NCT04501718
Treatments Being Tested
To compare the therapeutic effect of vinorelbine used alone or combined wit...
Status
Unknown
Location
Multiple Locations
Start Date
2019-06-24
Trial ID
NCT03932526
Treatments Being Tested
This study was designed to evaluate the effectiveness and safety of hepatic...
Status
Unknown
Location
Sun Yat-sen University Cancer Center
Start Date
2022-06-15
Trial ID
NCT05313282
To evaluate the clinical efficacy and safety of camrelizumab combined with ...
Status
Unknown
Location
The First Affiliated Hospital of Xiamen University
Start Date
2020-01-01
Trial ID
NCT04572542
Treatments Being Tested